Human papillomarivus vaccines for cervical cancer
RW Tindle - Current opinion in immunology, 1996 - Elsevier
Current opinion in immunology, 1996•Elsevier
The association of carcinoma of the uterine cervix with human papillomavirus indicates that
vaccine strategies which target the virus could be useful in the control of disease
progression. Recent advances have centered on directing the immune response to
prevention of infection, to virus-infected (but nontransformed) cells and to virally transformed
cells, with favourable results.
vaccine strategies which target the virus could be useful in the control of disease
progression. Recent advances have centered on directing the immune response to
prevention of infection, to virus-infected (but nontransformed) cells and to virally transformed
cells, with favourable results.
The association of carcinoma of the uterine cervix with human papillomavirus indicates that vaccine strategies which target the virus could be useful in the control of disease progression. Recent advances have centered on directing the immune response to prevention of infection, to virus-infected (but nontransformed) cells and to virally transformed cells, with favourable results.
Elsevier
